273 related articles for article (PubMed ID: 31535409)
1. Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
Yin X; Huang S; Xu A; Fan F; Chen L; Sun C; Hu Y
J Cell Biochem; 2020 Feb; 121(2):1563-1574. PubMed ID: 31535409
[TBL] [Abstract][Full Text] [Related]
2. [Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
Hosono N
Rinsho Ketsueki; 2019; 60(7):800-809. PubMed ID: 31391370
[TBL] [Abstract][Full Text] [Related]
3. Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).
Zhang R; Kim YM; Wang X; Li Y; Lu X; Sternenberger AR; Li S; Lee JY
Int J Med Sci; 2015; 12(9):719-26. PubMed ID: 26392809
[TBL] [Abstract][Full Text] [Related]
4. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
[TBL] [Abstract][Full Text] [Related]
5. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
[TBL] [Abstract][Full Text] [Related]
6. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of
Abbas HA; Ayoub E; Sun H; Kanagal-Shamanna R; Short NJ; Issa G; Yilmaz M; Pierce S; Rivera D; Cham B; Wing S; Li Z; Hammond D; Jabbour E; Borthakur G; Garcia-Manero G; Andreeff M; Daver N; Kadia T; Konopleva M; DiNardo C; Ravandi F
Leuk Lymphoma; 2022 Dec; 63(13):3105-3116. PubMed ID: 36089905
[TBL] [Abstract][Full Text] [Related]
8. Del(5q) and MLL amplification in homogeneously staining region in acute myeloblastic leukemia: a recurrent cytogenetic association.
Herry A; Douet-Guilbert N; Guéganic N; Morel F; Le Bris MJ; Berthou C; De Braekeleer M
Ann Hematol; 2006 Apr; 85(4):244-9. PubMed ID: 16425025
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
El-Menoufy MAM; Mourad ZI; Farahat NM
J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
[TBL] [Abstract][Full Text] [Related]
10. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.
Hasle H; Alonzo TA; Auvrignon A; Behar C; Chang M; Creutzig U; Fischer A; Forestier E; Fynn A; Haas OA; Harbott J; Harrison CJ; Heerema NA; van den Heuvel-Eibrink MM; Kaspers GJ; Locatelli F; Noellke P; Polychronopoulou S; Ravindranath Y; Razzouk B; Reinhardt D; Savva NN; Stark B; Suciu S; Tsukimoto I; Webb DK; Wojcik D; Woods WG; Zimmermann M; Niemeyer CM; Raimondi SC
Blood; 2007 Jun; 109(11):4641-7. PubMed ID: 17299091
[TBL] [Abstract][Full Text] [Related]
11. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
[TBL] [Abstract][Full Text] [Related]
12. Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.
Schoch C; Kohlmann A; Dugas M; Kern W; Hiddemann W; Schnittger S; Haferlach T
Leukemia; 2005 Jul; 19(7):1224-8. PubMed ID: 15902281
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia with isolated del(5q) is associated with IDH1/IDH2 mutations and better prognosis when compared to acute myeloid leukemia with complex karyotype including del(5q).
Rea B; Aggarwal N; Yatsenko SA; Bailey N; Liu YC
Mod Pathol; 2020 Apr; 33(4):566-575. PubMed ID: 31685963
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
15. [Complex additional chromosomal abnormalities of del(5q), del(7q), and +22 in a patient with acute myelomonocytic leukemia carrying inv(16)].
Nakaya A; Fujita H; Tachibana T; Takemura S; Ishigatsubo Y
Rinsho Ketsueki; 2004 Sep; 45(9):1061-3. PubMed ID: 15510837
[TBL] [Abstract][Full Text] [Related]
16. Recurrent genetic defects on chromosome 5q in myeloid neoplasms.
Hosono N; Makishima H; Mahfouz R; Przychodzen B; Yoshida K; Jerez A; LaFramboise T; Polprasert C; Clemente MJ; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Sanada M; Cui E; Verma AK; McDevitt MA; List AF; Saunthararajah Y; Sekeres MA; Boultwood J; Ogawa S; Maciejewski JP
Oncotarget; 2017 Jan; 8(4):6483-6495. PubMed ID: 28031539
[TBL] [Abstract][Full Text] [Related]
17. Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network.
Fang J; Barker B; Bolanos L; Liu X; Jerez A; Makishima H; Christie S; Chen X; Rao DS; Grimes HL; Komurov K; Weirauch MT; Cancelas JA; Maciejewski JP; Starczynowski DT
Cell Rep; 2014 Sep; 8(5):1328-38. PubMed ID: 25199827
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
19. Absence of point mutations within the AML-1 gene in patients with MDS/AML and loss of chromosome 5q or 7.
Ferrari T; Weber B; Pils S; Harbott J; Borkhardt A
Ann Hematol; 2001 Feb; 80(2):72-3. PubMed ID: 11261327
[TBL] [Abstract][Full Text] [Related]
20. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
